About
Stem Cell Technologies
Areas of Focus
Categories
Small Molecule PharmaceuticalStem Cell & Cellular TherapySeattle/Pacific Northwest
Team (9)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
260
By Phase
PHASE1: 1NA: 1PHASE1/PHASE2: 1
By Status
NOT_YET_RECRUITING: 1COMPLETED: 1RECRUITING: 1AVAILABLE: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT04366115Lead Sponsor
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
PHASE1Not yet recruiting
16 participants
Started: Dec 1, 2026 · Completed: Mar 1, 2032
NCT06113757Lead Sponsor
Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease
NACompleted
100 participants
Started: Sep 1, 2022 · Completed: Apr 15, 2024
NCT04329728Lead Sponsor
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
PHASE1/PHASE2Recruiting
144 participants
Started: Nov 6, 2020 · Completed: Dec 1, 2026
NCT05974410Lead Sponsor
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
N/AAVAILABLE
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...